IPO registrations (S-1, F-1) · Registrants

Strongbridge Biopharma plc

SEC CIK
1634432 · filings on EDGAR ↗
Former names
Cortendo AB (2015–2015)
Registration
Form F-1, first filed 2015-08-28, last 2015-10-14; 1 initial registration, 5 amendments
Outcome
Final prospectus filed 2015-10-16; declared effective 2015-10-15
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
L2
Business address
900 NORTHBROOK DRIVE, SUITE 200, Trevose, PA 19053
EIN
98-1130690
EDGAR entity type
operating
Insiders and CEO pay
Strongbridge Biopharma plc on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2015-10-16, an initial public offering)
Shares sold
2,500,000
Gross proceeds
$25,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol SBBP
Lead underwriters
Stifel
Syndicate
JMP Securities (500,000); Roth Capital Partners (312,500); Arctic Securities; Arctic Securities AS (125,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 10

FiledFormWhat it isName as filedEDGAR
2015-08-28F-1F-1 (foreign registration)Cortendo AB0001047469-15-007060 ↗
2015-09-09F-1/AF-1/A (amendment)Strongbridge Biopharma plc0001047469-15-007207 ↗
2015-09-21F-1/AF-1/A (amendment)Strongbridge Biopharma plc0001047469-15-007440 ↗
2015-09-25F-1/AF-1/A (amendment)Strongbridge Biopharma plc0001047469-15-007543 ↗
2015-09-30F-1/AF-1/A (amendment)Strongbridge Biopharma plc0001047469-15-007618 ↗
2015-10-14F-1/AF-1/A (amendment)Strongbridge Biopharma plc0001047469-15-007854 ↗
2015-10-15EFFECTEFFECT (declared effective)Strongbridge Biopharma plc9999999995-15-002760 ↗
2015-10-16424B4424B4 (final prospectus)Strongbridge Biopharma plc0001047469-15-007903 ↗
2017-02-02EFFECTEFFECT (declared effective)Strongbridge Biopharma plc9999999995-17-000275 ↗
2017-05-08EFFECTEFFECT (declared effective)Strongbridge Biopharma plc9999999995-17-001223 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-10-14F-1/Aregistration statement$10.002,500,000$25,000,000Nasdaq SBBP4primary document; price sentence, shares headline, proceeds computed, cover names 4document ↗
2015-10-16424B4final prospectus$10.002,500,000$25,000,000Nasdaq SBBP5primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Cohen Fredric J.OfficerChief Medical Officer122018–2021
DAVIS A BRIANOfficerChief Financial Officer42018–2019
JOHNSON JOHNDirector; Director,OfficerChief Executive Officer; Executive Chairman122018–2021
Kollender Richard SDirector; OfficerChief Operating Officer; President and CFO112018–2021
Kong GarhengDirector92018–2021
LONG STEPHEN JOfficerChief Legal Officer92018–2021
Pauls MatthewDirector,OfficerPresident & CEO42018–2019
SHERMAN JEFFREY WDirector92018–2021person page Fuzzy
Steen MartenDirector92018–2021
Steineger Hilde HDirector92018–2021
BARRETT M JAMESTenPercentOwner12018
BARRIS PETER JTenPercentOwner12018
BASKETT FORESTTenPercentOwner12018
CAXTON CORPTenPercentOwner102018–2022
CDK ASSOCIATES, L.L.C.TenPercentOwner102018–2022
Florence Anthony A. Jr.TenPercentOwner12018
Growth Equity Opportunities Fund III, LLCTenPercentOwner12018
KERINS PATRICK JTenPercentOwner12018
Kovner BruceTenPercentOwner102018–2022
MOTT DAVID MTenPercentOwner12018
NEA 14 GP, LTDTenPercentOwner12018
NEA Partners 14, L.P.TenPercentOwner12018
New Enterprise Associates 14, L.P.TenPercentOwner12018
SANDELL SCOTT DTenPercentOwner12018
Sonsini Peter W.TenPercentOwner12018
Viswanathan RaviTenPercentOwner12018
Wilhoit Scott L.OfficerChief Commercial Officer72019–2021
GILL DAVID NDirector92019–2021
Lutz Robert MatthewOfficerChief Financial Officer42019–2021

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-12-30Strongbridge Biopharma plcPharmaceuticals$35,000,000$35,000,000231
2015-09-14Strongbridge Biopharma plcPharmaceuticals$126,000,000$126,000,000461
2015-07-17Cortendo ABPharmaceuticals$33,224,981$33,224,981251
2015-02-25Cortendo ABPharmaceuticals$26,397,676$26,397,67651

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorSTRONGBRIDGE BIOPHARMA PLCPAForm 5500 (employee benefit plans)name and state
Form D issuerStrongbridge Biopharma plcPAForm D private offeringsCIK (EXACT)
Lobbying clientSTRONGBRIDGE BIOPHARMA PLCPAFederal lobbying (LDA)name and state
Lobbying clientSTRONGBRIDGE BIOPHARMA, PLCPAFederal lobbying (LDA)name and state
SEC filerStrongbridge Biopharma plcSEC filers (EDGAR)CIK (EXACT)
Person pageJeffrey W ShermanPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Pharmaceutical Preparations · Health